Sherlock Biosciences will develop molecular diagnostics tools co-developed by researchers at Harvard University and Broad Institute, including Crispr inventor Feng Zhang.

US-based biotechnology developer Sherlock Biosciences was launched out of Harvard University yesterday with a total of $35m in financing, including $17.5m in series A funding provided by the Open Philanthropy Project and unnamed investors.
The other $17.5m were supplied in the form of a non-dilutive grant by the Open Philanthropy Project, a non-profit group primarily funded by Dustin Moskovitz, a co-founder of social media firm Facebook, and his wife Cari Tuna.
The spinout is reportedly raising additional series…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).